| |
PRODUCTS, SERVICES
Pharmaceuticals
Monoclonal Antibody Human Cancer Therapy Biopharmaceuticals
Therapeutic Monoclonal Antibodies
human therapeutic monoclonal antibody therapy, chemotherapy cancer antibody development research, therapeutic MAbs, monoclonal antibodies
|
 |
Showing 1-25
of 25
 = product catalog / search specs
|
|
|
Alexion Pharmaceuticals - Monoclonal Antibody Cancer Treatment, Autoimmune Disorders, Hematologic, Stock Symbol ALXN
Cheshire, CT USA 203 272 2596 |
|
Alexion Pharmaceuticals $260 Million sales 700 employees
|
AstraZeneca Pharmaceutical - Medimmune, Cambridge Antibody - Respiratory, Cardiovascular, Vaccines, Stock Symbol AZN (London, ADR)
London UK 44.20.7304.5000 |
|
AstraZeneca $26.1 Billion US Dollar sales 65,000 employees 4th largest pharmaceutical $15.2 Billion Medimmune May 2007 acquisition, cardiovascular pharmaceuticals, gastrointestinal, antibiotics, neuroscience, asthma respiratory, cancer oncology
|
Biocon - Syngene, Clinigene - Biopharmaceuticals, API Active Pharmaceutical Ingredients, Generics, Stock Symbol 532523 (India)
Bangalore India 91 80 2808 2808 |
|
Biocon Syngene 11 Billion Rupee sales, $257 Million USD sales 3600 employees monoclonal antibodies, insulin, streptokinase, EPO, GCSF, generic nephrology pharmaceuticals, cardiology drugs, diabetic medication, biopharm contract manufacturing services
|
Biotest AG - Human Blood Plasma Protein Therapeutics, Reagents, Particle Counter, Hygiene Monitor, Stock Symbol BIO3 (Germany)
Dreieich Germany 49 6103 8010 |
|
Biotest AG 420 Million Euro sales ($590 Million USD sales) 1800 employees, Nov 2009 divested medical diagnostic instruments to Bio-Rad
|
Bioventix - Sheep Hybridoma High Affinity Sheep Monoclonal Antibodies SMA, Cancer Therapy , Private Ownership
Slough, Berkshire UK 44 125272 8001 |
|
|
CuraGen Corp - Biopharmaceutical Monoclonal Antibody Cancer Therapy Treatment Research , Stock Symbol CRGN
Branford, CT USA 203 481 1104 |
|
|
CytImmune Sciences Inc - Biopharmaceutical Oncology Therapeutic Nano-Scale Drug Development, Private Ownership
Rockville, MD USA 240 864 2796 |
|
|
Dyax Corp - Biotherapeutic Monoclonal Antibody Protease Tumor Inhibitor, Plasma Kallikrein Regulator, Stock Symbol DYAX
Cambridge, MA USA 617 225 2500 |
|
|
Fusion Antibodies Ltd - Biopharmaceutical Therapeutic Cancer Treatment Monoclonal Antibodies , Private Ownership
Belfast Northern Ireland 44 289043 2800 |
|
|
Genzyme - Pharmaceuticals, Oncology Monoclonal Antibody , Enzymes, Renal, Burn Autografts, Stock Symbol GENZ
Cambridge, MA USA 617.252.7500 |
|
Genzyme $3.9 Billion sales 9900 employees, lysomal storage disorder enzyme replacement therapy, Gaucher disease, Fabry, kidney treatment, osteoarthritis, immuno-transplant polyclonal antibody, cultured skin autograft, chondrocytes cartilage
|
Human Genome Sciences Inc (HGS) - Chronic Hepatitius C Treatment, Systemic Lupus, Anthrax , Stock Symbol HGSI
Rockville, MD USA 301 309 8504 |
|
HGS Human Genome Sciences Inc $45 Million sales 900 employees, human monoclonal antibody therapy, albumin fusion alpha interferon, solid tumor cancer targeted antibody therapy biopharmaceuticals
|
Immunomedics Inc - Murine Monocloncal Antibody IgG Fab Fragment Cancer Tumor Diagnosis, Therapy , Stock Symbol IMMU
Morris Plains, NJ USA 973 605 8200 |
|
|
MacroGenics Inc - Raven Biotechnologies - Monoclonal Antibody Cancer Treatment Immunotherapeutics, Private Ownership
Rockville, MD USA 301 251 5172 |
|
MacroGenics Inc monoclonal antibody autoimmunity treatment research, infectious disease monoclonal antibodies, cancer therapy clinical trials, July 2008 Raven Biotechnologies acquisition
|
Merck Co - Schering Plough - Pharmaceuticals, Vaccines, Dr Scholls, Merck Manual Drug Reference, Stock Symbol MRK
Whitehouse Station, NJ USA 908 423 1000 |
|
Merck $42 Billion Sales 101,000 employees 4th largest global pharmaceutical, respiratory hypertension, osteoporosis, Vioxx cardiovascular, Zocor cholesterol, monoclonal antibodies skin anti-fungal, March 2009 $41 Billion Schering Plough acquisition
|
Merck KGaA - Serono - Pharmaceuticals, Chemicals, Pigments, Cough Cold Medicine, Stock Symbol MRCG.DE (Xetra, Germany)
Darmstadt, Germany 49.61.51.72.5000 |
|
Merck KGaA 7.1 Billion Euro sales ($10 Billion USD sales) 31,000 employees, No affiliation with US Merck, high blood pressure, diabetes treatment, lipid metabolism, thyroid, cancer monoclonal antibody, herbal medicine, cod liver oil, vitamin C
|
MorphoSys - AbD Serotec - Therapeutic Human Monoclonal Antibody Therapy, Research Antibodies, Stock Symbol MORG (Xetra Frankfurt Germany)
Martinsried Planegg Germany 49 89899 270 |
|
Morphosys 52 Million Euro sales, human antibodies, mouse rate fish antibodies, reagents, cytokines
|
Neugenesis Corp - Biopharmaceutical Drug Monoclonal Antibodies, Multivalent Vaccines, Private Ownership
Burlingame, CA USA 650 689 2220 |
|
|
Northwest Biotherapeutics (NWBT) - Cancer Therapy Monoclonal Antibodies, Brain, Prostate Cancer, Stock Symbol NWBO
Bethesda, MD USA 240 497 9024 |
|
|
PDL Biopharma Inc - Protein Design Labs - Targeted Cancer Monoclonal Antibodies , Stock Symbol PDLI
Incline Village, NV USA 775 832 8500 |
|
|
Peregrine Pharmaceuticals Inc - Monoclonal Antibody Cancer Therapy, Hepatitis C Infection Treatment, Stock Symbol PPHM
Tustin, CA USA 714 508 6000 |
|
|
PharmAthene - SIGA - Biodefense Antibody Drug Development, Anthrax, Smallpox, Chemical Nerve Agents, Stock Symbol SIGA
Annapolis, MD USA 410 269 2600 |
|
|
Roche - Genentech - Biopharmaceuticals, Growth Hormone, Monoclonal Antibodies, Chemotherapy, Stock Symbol ROG (Switzerland), RHHBY (ADR)
South San Francisco, CA USA 650 225 1000 |
|
Genentech $12.5 Billion sales 11,000 employees, monoclonal antibody therapy, lymphoma lung cancer chemotherapy drugs, psoriasis treatment, human growth hormone, tissue plasminogen activator, cystic fibrosis, March 2009 Roche acquisition $46 Billion
|
Seattle Genetics Inc - mAb Monoclonal Antibody Cancer Therapy Clinical Trial Research , Private Ownership
Bothell, WA USA 425 527 4000 |
|
|
Xencor Inc - Protein Therapeutics Research, Monoclonal Antibodies, Phase I Lymphoma , Private Ownership
Monrovia, CA USA 626 305 5900 |
|
|
XOMA - Therapeutic Cancer Antibodies, Biodefense, Autoimmune Clinical Trials, Infectious Disease, Stock Symbol XOMA
Berkeley, CA USA 510 204 7200 |
|
|
| Showing 1-25
of 25
|
|
